• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Genetics of alcohol-related hepatocellular carcinoma - its role in risk prediction

    2020-07-21 09:39:14KenLiuGontranVersetEricTrepoDevanshiSeth
    Hepatoma Research 2020年7期

    Ken Liu, Gontran Verset, Eric Trepo, Devanshi Seth,5

    1Centenary Institute of Cancer Medicine and Cell Biology, The University of Sydney, Sydney, NSW 2006, Australia.

    2Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.

    3Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB H?pital Erasme, Université Libre de Bruxelles, Brussels 1070, Belgium.

    4Laboratory of Experimental Gastroenterology, Université Libre de Bruxelles, Brussels 1070, Belgium.

    5Drug Health Services, Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW 2050, Australia.

    Abstract Hepatocellular carcinoma (HCC) is the most common primary liver malignancy, with increasing incidence worldwide. Alcohol-related cirrhosis (AC) accounts for 30% of the global incidence of HCC and HCC-related deaths. With the decline of hepatitis C virus (HCV) and decreasing HCV-related HCC, AC will soon become the leading cause of HCC. Excess alcohol consumption (> 80 g per day for > 10 years) increases the risk of HCC by 5-fold. However, only up to 35% of excessive drinkers develop cirrhosis and its associated HCC risk. Individual variation in susceptibility to HCC is known, but there is limited information to predict who among the patients is at high risk of progressing to HCC. Clinical risk factors for HCC include male gender, older age, severity of cirrhosis, obesity and presence of type 2 diabetes. In addition to ethnic variability in HCC risk, genetic variants are known to alter the risk of alcohol-related HCC. For example, single nucleotide polymorphisms in PNPLA3(rs738409, C>G) and TM6SF2 (rs58542926, C>T) increase the risk of AC-related HCC, whereas HSD17B13(T>A) reduces the risk for HCC. Studies have also confirmed PNPLA3 and TM6SF2 to be independent risk factors for AC-related (but not HCV-related) HCC. Combining genetic risk factors with phenotypic/clinical risk factors has been explored for stratification of patients for HCC development. Risk allele rs378409-G in PNPLA3 when combined with phenotypic/clinical risk factors (BMI, age, sex) has enabled HCC risk stratification of AC patients into low-, intermediate- and high-risk subgroups. Similarly, a combination of the two genetic variants PNPLA3-G and TM6SF2-T has been independently associated with risk of HCC onset. Using a polygenic risk score approach of incorporating several genetic variants, prognostic performance of polygenic risk score that included PNPLA3 rs378409 and TM6SF2 rs58542926 improved HCC prediction better than with either variant alone. Incorporating new variants and risk factors has the potential to build better algorithms/models to predict onset, early diagnosis and treatments for AC-related HCC. However, clinical usefulness of these approaches is yet to be determined.

    Keywords: Alcohol-related cirrhosis, PNPLA3, HSD17B13, TM6SF2, risk prediction

    INTRODUCTION

    Hepatocellular carcinoma (HCC) is the most common primary liver malignancy, with increasing incidence worldwide[1]. Despite screening programs in high-risk populations, long-term outcome is poor with a 5-year survival of 18%, representing the world’s third most lethal cancer. More specifically, the World Health Organization estimates that more than a million patients will die from liver cancer in 2030[2].

    In almost 90% of cases, HCC occurs in the context of chronic liver disease, in particular, on the background of cirrhosis[1,3]. The underlying chronic liver disease promoting liver carcinogenesis varies geographically[1].In Asia and sub-Saharan Africa, HCC is mostly caused by hepatitis B virus infection, while in the United States and Europe the current leading etiologies are hepatitis C virus (HCV) infection and alcohol-related cirrhosis (AC) followed by non-alcohol-related fatty liver disease (NAFLD)[4]. However, the advent of new direct-acting antiviral agents is expected to control HCV-related HCC in upcoming years, and AC will soon become the leading cause of HCC in most high-income countries[1]. Clinical risk factors for HCC occurrence include male gender, older age, severity of cirrhosis, obesity and presence of type 2 diabetes[5-7].Clinical risk models have shown that the individual risk of HCC development is highly variable[6]. In addition, case-control and cancer database studies have highlighted the impact of ethnic background and a significant familial clustering[8,9]. For example, individuals of African and Hispanic ancestry are less likely to undergo curative therapies[10]. Overall, these observations strongly suggest that inherited genetic factors contribute to hepatocarcinogenesis.

    Here, we review the current literature on risk factors, with a particular focus on genetic risk variants for alcohol-related HCC occurrence.

    EPIDEMIOLOGY AND CHARACTERISTICS OF ALCOHOL-RELATED HCC

    Alcohol-related HCC occurs infrequently in patients without pre-existing cirrhosis. Cirrhosis (of any etiology) is the single biggest risk factor for HCC development[3,11,12]. The annual incidence of HCC in patients with AC is nearly 3%[13]. The risk of developing AC and HCC parallels the amount of alcohol consumed daily and significantly increases above a threshold of 20 and 30 g for females and males,respectively[14,15]. Heavy alcohol drinking of more than 80 g per day for longer than 10 years increases the risk of HCC by 5-fold[16]. More specifically, AC accounts for 30% of the global incidence of HCC and HCCrelated deaths, with marked geographical differences[17]. In Europe, HCC occurrence on the background of alcohol-related liver disease (ALD) varies from 20% in the south (e.g., Italy or Spain), to 63% in eastern countries. In the United States, alcohol accounts for 13% to 23% of HCC cases. Finally, the prevalence of alcohol-related HCC reaches 6% in the Middle East and 14% in North Africa[17,18]. The influence of alcohol consumption has also been highlighted by the impact of alcohol withdrawal on HCC development. Thus, a meta-analysis reported an annual reduction of HCC risk by 6%-7%[19].

    However, only up to 10%-35% of excessive drinkers develop advanced fibrosis or cirrhosis and its associated HCC risk[20]. Interestingly, the role of alcohol consumption seems to be milder or even negligible compared to other environmental factors in the setting of HCC occurring in a non-fibrotic liver. For example, a recent case-control study observed that after adjustment of smoking habits and metabolic syndrome features,alcohol consumption was no longer independently associated with HCC in individuals with F0-F1 fibrosis stage[21].

    HCC is often diagnosed at a later Barcelona Clinic Liver Cancer (BCLC) stage in patients with ALD and with a more severe underlying cirrhosis leading to a worse prognosis compared to other liver diseases[14,22].A previous study reported that patients with alcohol-related HCC are often younger and are more frequently diagnosed with a multifocal or infiltrative/massive tumor compared to HCV-related HCC.However, this apparent greater cancer aggressiveness disappeared after adjusting for confounding factors,and prognosis was similar in ALD and HCV patients when stratified by BCLC stages[23]. Moreover, a recent study did not show significant differences in tumor characteristics between patients with AC- and NAFLD-related HCC[24]. Overall, the higher proportion of advanced BCLC stages observed in ALD/AC patients might only reflect a lower compliance with surveillance programs, rather than a greater tumor aggressiveness.

    LIMITATIONS OF SCREENING STRATEGIES IN PATIENTS WITH AC-RELATED HCC

    The American Association for the Study of Liver Diseases and European Association for the Study of the Liver recommend HCC surveillance in all cirrhotic patients using ultrasound, with or without alphafetoprotein determination, every 6 months[25,26]. This surveillance program has been shown to increase overall survival and improve the quality-adjusted life expectancy[27,28]. However, this periodic surveillance has been shown to be difficult to implement in daily clinical practice, ultimately leading to a significant prevalence of HCC detected at a more advanced stage[29]. Thus, more than 20% of HCC patients are also diagnosed with an unsuspected cirrhosis[30]. This phenomenon is even more pronounced in patients with ALD because AC is underdiagnosed due to their poor compliance in cancer surveillance programs[30].Therefore, risk factors identified for AC are potential candidates for susceptibility to HCC.

    Due to the aforementioned limitations, there is an urgent need for new detection strategies and the development of new highly sensitive, reliable, and easily accessible biomarkers that can either improve the early detection of HCC in high-risk patients with AC or identify individuals at risk of progressive ALD when liver fibrosis is incomplete and potentially reversible[31].

    Individual variation in susceptibility to HCC is known, but there is limited information to predict who among the patients is at high risk of progressing to HCC. A better understanding of the contributing molecular, genetic and epigenetic factors is required to identify drivers of and therapeutic options for hepatocarcinogenesis.

    CONTRIBUTION OF GENETIC VARIANTS TO THE PREDICTION OF ALCOHOL-RELATED HCC

    The association of genetic variants with the risk of alcohol-related HCC has been reported. Earlier studies targeted genes with known functions, specifically genes known to operate in the pathogenesis of ALD and recently proposed to be part of a “5-hit working model” of disease progression leading to HCC[32]. These candidate genes, involved in hepatic alcohol metabolism [alcohol dehydrogenase (ADH), acetaldehyde dehydrogenase (ALDH), ethanol-induced cytochrome P450 (CYP2E1), CYP2E1-dependent microsomal ethanol oxidizing system (MEOS)] and affecting downstream mechanisms including oxidative stress[CYP2E1, glutathione S-transferase (GST), manganese superoxide dismutase (MnSOD),N-acetyltransferase 2, ectonucleotide pyrophosphatase/phosphodiesterase 1, homeostatic iron regulator (HFE)], endotoxin release [CD14, toll-like receptor 4 (TLR4)], immune function (TNFα, IFNγ, IL-10, IL-1B, CD14) and fibrogenesis [TGFβ, angiotensin, leptin, metalloproteinases (MMPs), tissue inhibitors of MMPs (TIMPs)],have been extensively reviewed for their association to alter risk of ALD/AC and ALD-related HCC[12,33-35].But results from most of these earlier studies could not be replicated or confirmed due to limitations in technology, small sample size, inappropriate study population and not accounting for underlying ethnic variability. The most widely known genetic mutations altering the risk of ALD and ALD-HCC are in the alcohol-metabolizing enzymes. These mutations alter the enzyme kinetics of alcohol dehydrogenase (ADH)and acetaldehyde dehydrogenase (ALDH)[35,36]. ADH1B rs1229984 induces ADH activity and acetaldehyde formation, whereas ALDH2?2 rs671 reduces ALDH activity, impairing its ability to clear acetaldehyde[35,37].Carriage of both mutations results in the accumulation of toxic acetaldehyde levels with intense rise in arterial blood flow to the face, causing the well-known flushing and nausea. In East Asian populations with high prevalence of these mutations, this may result in reduced alcohol intake conferring protection against alcoholism[38]. Conversely, the risk of developing ALD and ALD-HCC increases in drinkers who carry one or both mutations[36].

    Recent technological advances such as genome-wide association studies (GWAS) and next-generation sequencing have added to the growing field of genetic and epigenetic factors that modulate the risk for ALD/AC-related HCC. In recent years, a few single nucleotide polymorphisms (SNPs) have been discovered that are associated with risk of AC[39-41]. The single most commonly reproduced association with liver cirrhosis is the rs738409 SNP (p. I148M) in patatin-like phospholipase domain protein 3(PNPLA3),which is also associated with increased HCC risk[42]. This C>G mutation is accompanied by a change from isoleucine to methionine at a conserved amino acid residue (I148M). Association of rs738409 (C>G) with increased risk of liver diseases has been confirmed in AC[40,41]and alcohol-related HCC[43,44]. Dose effect of the G-allele has been shown with ancestry-adjusted odds ratio (OR) increasing by 1.79 per G allele(P= 1.9 × 10-5) for ALD risk[45]and 1.77 (95%CI: 1.42-2.19,P= 2.78 × 10-7) per G allele for HCC[46].The influence of this variant on HCC risk prediction revealed that the rs738409 (GG) genotype was an independent risk factor specifically for alcohol- (but not HCV-) related HCC[46]. Moreover, OR among the AC patients with HCC increased from 2.87 (95%CI: 1.61-5.10) in carriers of the CG genotype to 12.41(95%CI: 6.99-22.03) in GG patients[43].

    A study in a Chinese population showed that rs17401966 (A>G) in kinesin-like factor 1 B(KIF1B), a tumor suppressor gene, was associated with risk of HCC. The risk of HCC was higher in carriers of the AA genotype, compared to GG or AG, but only in the presence of alcohol (OR 2.36, 95%CI: 1.49-3.74),suggesting an additive gene-environment interaction between rs17401966 and alcohol consumption[47]. But this association has not been confirmed. Similarly, rs641738 (C>T) in membrane-boundO-acyltransferase 7(MBOAT7), was identified as a risk locus for AC[40], but has yet to be replicated in other studies as a risk for AC/ALD or HCC.

    Another SNP, rs58542926 (?/T) in transmembrane 6 superfamily 2(TM6SF2), is strongly associated with the risk for HCC, particularly in patients with AC- and not HCV-related cirrhosis[44,48]. This variant was independently confirmed to be associated with HCC using a multivariate model adjusted for age, sex, BMI and diabetes (OR 2.5, 95%CI: 1.4-4.3)[48].

    SNPs in hydroxysteroid 17-beta dehydrogenase 13(HSD17B13) are associated with decreased liver transaminases and liver injury[49]. In particular, recently identified splice variant SNP rs72613567 (T>A),resulting in loss of function and reduced enzyme activity, also showed (1) interactions withPNPLA3rs738409 risk allele, with each rs72613567:TA allele lowering the increase in transaminase levels conferred by eachPNPLA3risk allele (I148M); and (2) allele dose-dependent association of rs72613567:TA with decrease inPNPLA3mRNA expression[39]. Importantly, this rs72613566 (T>A) was associated with lower odds of alcohol- and non-alcohol-related liver diseases/cirrhosis as well as lower risk for HCC. The lower risk conferred by rs72613567 variant wasPNPLA3allele-dependent for AC and was confirmed in both men and women[50]. However, the rs72613567-associated lower risk for HCC wasPNPLA3-dependent only in men[50].

    It is suggested that for risk of AC/ALD-related HCC,PNPLA3may be most relevant for the development of steatosis and ALD/AC, andTM6SF2andMBOAT7contributing towards HCC through inflammationdriven fibrosis[51]. Intriguingly, SNPs reported so far inPNPLA3, HSD17B13, TM6SF2andMBOAT7as being associated with AC/ALD are involved in lipid metabolism and processing, but their role in developing AC-ALD and HCC is yet to be clarified. Further investigations are required into the contribution of genetic factors individually and in combination with other variants, especially those influencing the effect on each other, such asPNPLA3andHSD17B13. Understanding the roles of SNPs in the biology of liver disease is still in its infancy, and there is limited literature on specific functions of these recently identified SNPs.Although some SNPs are shared among different etiologies of cirrhosis and HCC, the role or interaction of these SNPs remains unclear in complex etiologies that co-exist with AC, such as viral hepatitis and NAFLD-related HCC. Further investigations are required to delineate the contribution of these SNPs to HCC development.

    RISK STRATIFICATION FOR AC/ALD-RELATED HCC

    Using a combination of genetic risk factors with other phenotypic/clinical risk factors has been explored for the identification and stratification of patients for HCC development[46,48,52-56]. Using the rs378409 risk variant inPNPLA3in combination with other phenotype/clinical factors (BMI, age, sex) enabled HCC risk stratification of low-, intermediate- and high-risk AC patients (hazard ratio (HR 4.3, 95%CI: 2.7-6.4)[53].Similarly, a combination of the two genetic variantsPNPLA3-G andTM6SF2-T was independently associated with risk of HCC onset (HR 2.3, 95%CI: 1.5-3.4)[48]. Furthermore, the same study also reported that the number of HCC cases with carriage of bothPNPLA3-G andTM6SF2-T risk alleles was significantly higher than carriers of only one risk allele in either SNP.

    Most recently, a combination of all reported SNPs in AC, rs738409 (PNPLA3), rs6834314 (HSD17B13),rs58542926 (TM6SF2) and rs626283 (MBOAT7),when added to phenotypic factors (BMI, diabetes status,wine and coffee consumption), performed better [area under the curve (AUC) 0.748, 95%CI: 0.721-0.774], compared to only genetic factors (AUC 0.689, 95%CI: 0.660-0.717) or only phenotypic factors(AUC 0.681, 95%CI: 0.651-0.710), in stratifying drinkers with AC from drinkers with no liver disease[57].It is encouraging that combining information on genetic variants with other risk factors can improve the identification of patients at risk. Furthermore, these genetic variants have also been shown to modulate severity of NAFLD (and its progression to steatohepatitis, fibrosis and cirrhosis) which commonly co-exists with alcoholic liver disease patients as “dual-etiology fatty liver disease” and accelerates liver injury[58,59].

    Recently, the approach of incorporating several genetic variants in a so-called polygenic risk score (PRS)has been shown to be a successful strategy to improve the prediction of various complex phenotypes[60].Thus, this method has been shown to outperform existing clinical models for the prediction of breast cancer with personalized recommendation on screening[61]. Of note, the addition of other risk factors into a global predictive model improves the overall performances compared to PRS alone[62]. At the transcriptional level, gene expression signatures gathering several dozens of genes (i.e., Prosigna and MammaPrint) have been included by the European Society for Medical Oncology to its clinical practice guidelines as prognostic and predictive tools to determine the benefit from chemotherapy[63].

    The use of PRS to predict HCC occurrence in AC-related HCC patients is emerging[52,64]. More specifically,the prognostic performance of PRS includingPNPLA3rs738409 andTM6SF2rs58542926 was higher than when consideringPNPLA3andTM6SF2variants alone[52,64].

    Several other SNPs have been identified as being associated with the risk of HCC, particularly with a viral etiology, but the literature is sparse regarding genetic variants specifically in relation to alcohol-related HCC. Similarly, contributions of molecular markers[65-67], somatic mutations[68], chromosomal instability and tumor microenvironment[69], and other regulatory components, such as mRNAs[70], noncoding RNAs[65,71], epigenetic[71,72]and mitoepigenetic factors[73]influencing the risk of alcohol-related HCC are few and overlap with other etiologies[69,71]. Last but not least, the role of the gut microbiota (fungi, bacteria and viruses), is another emerging factor influencing disease risk in ALD and ALD-HCC[74,75]. The gut microbiota also engages in alcohol metabolism, thereby altering the risk for ALD pathogenesis. Changes in the gut microbiome significantly correlates with alcohol consumption in human and experimental models,and there is evidence that alcohol and gut metabolites in ALD patients show carcinogenic effects[74],potentially increasing the risk of HCC.

    Genomic studies have revealed several subclasses of HCC. Alcohol-related HCC is associated withCTNNB1mutations (WNT-β-catenin signalling pathway); however, direct translation of molecular HCC subclasses into clinical management (i.e., personalized medicine) is yet to be achieved[76]. The recent success of checkpoint inhibitors in HCC has led to a renewed interest in immunological profiling of HCC and opportunities for personalized medicine. Recently, Siaet al.[77]analyzed the gene expression pattern of inflammatory cells in HCCs of almost 1000 patients. The authors identified a novel molecular class of tumors (in approximately 25% of patients) with an enriched inflammatory response characterized by overexpression of immune-related genes and high expression of PD1 and PD-L1 which may predict response to checkpoint inhibitor immunotherapy. A study by The Cancer Genome Atlas consortium performed multi-platform integrative molecular subtyping on 196 HCCs and found a similar subset of patients with high lymphocyte infiltration (in 22% of patients)[78]. Of note, the authors showed that the aforementionedCTNNB1mutation was associated with a lack of immune infiltrate (so-called cold tumors),which has been observed by others[78,79]. In a recent first report of prospective genotyping of advanced HCC by next-generation sequencing,CTNNB1mutations were associated with primary resistance to immune checkpoint inhibitors[80]. Patients exhibitingCTNNB1mutations all had progressive disease as their best response and a shorter median survival compared to those without mutations (9.1 monthsvs.15.2 months,respectively). Clearly, the immunological classification of alcohol-related HCCs will become increasingly important as immune-based therapies are added to the limited therapeutic options for patients with advanced disease.

    With the discovery of new variants and risk factors, there is the potential to incorporate them for building prediction algorithms/models for AC/ALD-HCC onset, early diagnosis and treatments.

    CLINICAL APPLICATIONS OF RISK-STRATIFIED AC/ALD-HCC PATIENTS

    In terms of clinical application, patients identified by the above genetic modifiers to be at high risk of developing significant liver fibrosis may be prioritized for early referral to specialist care, with those at low risk remaining in primary care. These select high-risk patients can then be linked with resource-intensive multidisciplinary and evidence-based care involving hepatologists, psychiatrists, and addiction specialists to maximize their chance of obtaining abstinence. Indeed, when prolonged abstinence is achieved, it has been shown to lead to resolution of steatosis and inflammation and even fibrosis regression in some (but not all) patients[81,82]. Specialist care can also facilitate access to closer monitoring of liver fibrosis using noninvasive tests (e.g., transient elastography, magnetic resonance elastography) and prompt commencement of HCC surveillance (discussed below) when patients are diagnosed with cirrhosis.

    Risk stratification for HCC surveillance

    Figure 1. Potential clinical applications of genetic-based tests in alcoholic cirrhosis and related hepatocellular carcinoma. ?It would be unethical to use genetic tests in the pre-transplant setting to determine if a patient should be offered liver transplantation. AFP: alphafetoprotein; CT: computed tomography; HCC: hepatocellular carcinoma; MRI: magnetic resonance imaging

    Aside from the prediction of patients at risk of advanced fibrosis or cirrhosis, genetic variants (e.g.,PNPLA3, TM6SF2andHSD17B13) can also help predict HCC development. As mentioned, these genes predisposing to alcohol-related HCC can be incorporated with other established risk factors for HCC(e.g., male sex, age and obesity) into a validated scoring system to risk-stratify patients for tailored HCC surveillance. Indeed, risk calculators for HCC development already exist for other liver diseases such as chronic hepatitis B and hepatitis C infection[83,84]. It is likely that the combination of several genetic variants(rather than any single SNP) with or without clinical variables into a score will be most predictive. Since the surveillance interval of 6 months for patients[85]was determined on the basis of estimated tumor doubling time (rather than tumor development risk), shortening intervals (e.g., to every 3 months) for ALD patients classified as high-risk may not result in improved outcomes[86]. However, risk calculators may help identify high-risk patients without cirrhosis, who should undergo surveillance (akin to surveillance of noncirrhotic chronic hepatitis B patients) or those who should be surveyed with a more sensitive modality (e.g.,computed tomography scan or magnetic resonance imaging). Conversely, risk scores may select out a lowrisk group of patients with ALD who can safely forego surveillance, especially in resource-poor settings[Figure 1]. The development and application of risk scores using genetics needs to be explored further.

    Given the rise of alcohol-related HCC in the post-HCV era, it is imperative that more research be conducted in this area, providing a deeper understanding of the underlying risks and early diagnosis of HCC in patients with ALD. Possibilities exist of repurposing biomarkers and therapeutic agents for alcoholrelated HCC identified/used for other etiologies.

    CHALLENGES OF CURRENT RISK PREDICTION MODELS FOR ALCOHOL-RELATED HCC

    Risk prediction for alcohol-related HCC has been critically missing in the past due to lack of reproducible genetic studies. Recent discoveries on several genetic risk associations with AC have opened the field for using this information for risk prediction, not only for cirrhosis but also for alcohol-related HCC in patients with alcohol use problems.

    The contribution of genetic variants, especiallyPNPLA3rs738409, as potential predictors for ACrelated HCC has been frequently discussed mainly because ORs often are > 2, calculated in retrospective cohorts[46]. However, modest to large ORs and extreme statistical significance do not automatically imply clinical relevance and other statistical metrics such as sensitivity, specificity and negative/positive predictive values might be more relevant[87]. Although variants inPNPLA3,TM6SF2and more recentlyHSD17B13modulate the risk of AC-related HCC, the use of these variants in HCC surveillance programs is currently not recommended[25,26].

    Even though predictive models for HCC have generally been successful, they have limited clinical utility currently, especially the use of genetic-based factors identified in one ethnic population but used for prediction in another population. Although recent use of PRS for identification/stratification of at-risk patients is promising, one important limitation of PRS is their applicability in non-European ancestry populations. Indeed, most of the variants used in PRS have been identified in GWAS overwhelmingly conducted in individuals of European descent[88]. Therefore, the applicability of current PRS is not guaranteed[89]. Failure to include individuals from diverse ancestry will hamper the use of PRS in the multiethnic population seen in clinical practice[90]. At the level of gene expression, a 186-gene signature,initially developed to predict HCC recurrence in HCV-infected patients, has shown promising predictive ability for hepatocarcinogenesis in AC patients[91].

    A particular challenge with alcohol-related liver diseases, including HCC, is the complication of alcohol dependence in these patients. Only select patients with alcohol-related HCC undergo liver transplantation(LT). After LT, up to 50% of patients relapse to drinking with 20% returning to harmful drinking with potential recurrence of liver disease[92]. The heritability of alcohol dependence has previously been estimated to be 25%-50%, and variants in genes encoding alcohol metabolism enzymes (ADH, ALDH)and GABA neurotransmission (GABRA2) have been shown to be associated with alcohol misuse[93].Whether these same markers can predict (beyond current clinical markers) recidivism post-LT is currently unknown, so this presents an opportunity for further study. Transplanted patients identified to be at high risk of relapse can be preferentially referred for participation in multidisciplinary relapse prevention programs, which have been shown to be effective[94]. The prediction of relapsers post-LT will be increasingly important as transplant indications have recently expanded to include select patients with severe alcoholic hepatitis without significant prior abstinence[95].

    Overall, PRS and gene expression signatures in combination with environmental risk factors have the potential to improve the prediction of alcohol-related HCC and pinpoint high-risk individuals. However,to date, evidence of clinical usefulness in this field is lacking. Thus, before genetic variation/expression can impact decision-making and be implemented in daily practice, it will need to be validated in large-scale prospective cohorts evaluating their clinical utility and cost-effectiveness[89,96]. Moreover, many physicians will require some training to interpret and communicate in a digestible manner the results of genetic testing and its current limitations[97].

    DECLARATIONS

    Authors’ contributions

    Led the overall concept, design, structure, writing, submission and revision of the manuscript in consultation with all co-authors: Seth D

    Risk stratification, HCC surveillance and treatment, Figure 1: Liu K

    Introduction, epidemiology of AC-HCC, risk prediction: Trepo E, Verset G

    Introduction, genetic variants, genetic variants risk prediction: Seth D

    All authors critically reviewed the manuscript.

    Availability of data and materials

    Not applicable.

    Financial support and sponsorship

    None.

    Conflicts of interest

    All authors declared that there are no conflicts of interest.

    Ethical approval and consent to participate

    Not applicable.

    Consent for publication

    Not applicable.

    Copyright

    ? The Author(s) 2020.

    404 Not Found

    404 Not Found


    nginx
    久久国内精品自在自线图片| 亚洲精华国产精华液的使用体验| 久久久久久久久久成人| 观看免费一级毛片| 99久久中文字幕三级久久日本| 1000部很黄的大片| 久久国产精品大桥未久av | 久久精品久久久久久久性| 少妇人妻精品综合一区二区| 欧美另类一区| 国产精品无大码| 美女主播在线视频| av播播在线观看一区| 国产真实伦视频高清在线观看| 午夜福利在线在线| 午夜福利高清视频| 午夜福利在线在线| 国产精品福利在线免费观看| 汤姆久久久久久久影院中文字幕| 这个男人来自地球电影免费观看 | 婷婷色麻豆天堂久久| 最近最新中文字幕免费大全7| 久久久久久久精品精品| 超碰97精品在线观看| 亚洲第一av免费看| 日本-黄色视频高清免费观看| 久久精品国产自在天天线| 国产精品爽爽va在线观看网站| 国产亚洲精品久久久com| 久久久久久久国产电影| 黄色日韩在线| 成人黄色视频免费在线看| 激情五月婷婷亚洲| 亚洲av免费高清在线观看| av线在线观看网站| 亚洲中文av在线| 国产黄频视频在线观看| 黑人猛操日本美女一级片| 一本一本综合久久| 少妇精品久久久久久久| 午夜福利在线观看免费完整高清在| 国产精品秋霞免费鲁丝片| 精品少妇久久久久久888优播| 欧美xxxx性猛交bbbb| 久久婷婷青草| 男女啪啪激烈高潮av片| 一本—道久久a久久精品蜜桃钙片| 精品少妇久久久久久888优播| 韩国av在线不卡| 成年女人在线观看亚洲视频| 22中文网久久字幕| 国产国拍精品亚洲av在线观看| 毛片一级片免费看久久久久| 热99国产精品久久久久久7| 久久99热这里只频精品6学生| 亚洲国产精品一区三区| 丰满乱子伦码专区| xxx大片免费视频| 青春草亚洲视频在线观看| 五月玫瑰六月丁香| 亚洲内射少妇av| 人人妻人人添人人爽欧美一区卜 | 久久久久久久久久久免费av| 我的女老师完整版在线观看| 精品久久久久久久末码| av在线app专区| 久久久久久久久久久免费av| 久久久久精品久久久久真实原创| 自拍欧美九色日韩亚洲蝌蚪91 | 99热国产这里只有精品6| 亚洲欧美精品专区久久| 菩萨蛮人人尽说江南好唐韦庄| 国精品久久久久久国模美| 欧美3d第一页| 精品酒店卫生间| 欧美日韩在线观看h| 久久ye,这里只有精品| 亚洲欧美日韩另类电影网站 | 久久99热这里只有精品18| 国产av国产精品国产| 国产精品久久久久久精品古装| 赤兔流量卡办理| 中文天堂在线官网| 伦理电影免费视频| 超碰97精品在线观看| 日日摸夜夜添夜夜添av毛片| 日韩av在线免费看完整版不卡| 2018国产大陆天天弄谢| 国产精品99久久99久久久不卡 | 国产久久久一区二区三区| 国产欧美亚洲国产| 亚洲怡红院男人天堂| 高清不卡的av网站| 亚洲美女搞黄在线观看| 国产免费福利视频在线观看| 有码 亚洲区| av女优亚洲男人天堂| 国产淫语在线视频| 中文字幕av成人在线电影| 国产精品免费大片| 妹子高潮喷水视频| 波野结衣二区三区在线| 亚洲精品色激情综合| 免费观看的影片在线观看| 中文在线观看免费www的网站| 色网站视频免费| 久久久久久伊人网av| av国产久精品久网站免费入址| 高清毛片免费看| 一个人看的www免费观看视频| 日韩制服骚丝袜av| av国产久精品久网站免费入址| 熟妇人妻不卡中文字幕| 插逼视频在线观看| 国产男女内射视频| 色视频www国产| 国产精品不卡视频一区二区| 亚洲成人中文字幕在线播放| 欧美成人一区二区免费高清观看| videos熟女内射| 色网站视频免费| 十分钟在线观看高清视频www | 卡戴珊不雅视频在线播放| 成人二区视频| 国产白丝娇喘喷水9色精品| 3wmmmm亚洲av在线观看| 亚洲,一卡二卡三卡| 中文字幕免费在线视频6| 看十八女毛片水多多多| 99热网站在线观看| 丝袜脚勾引网站| a级一级毛片免费在线观看| 久久久亚洲精品成人影院| 成人特级av手机在线观看| 在线免费观看不下载黄p国产| 97超碰精品成人国产| 国产精品成人在线| 国产精品久久久久久av不卡| 一个人免费看片子| 男人舔奶头视频| 久久ye,这里只有精品| 性色av一级| 人妻一区二区av| 免费观看a级毛片全部| 高清不卡的av网站| 精品久久久噜噜| 欧美xxⅹ黑人| 深爱激情五月婷婷| 国产在线一区二区三区精| 大陆偷拍与自拍| 精品午夜福利在线看| 国产精品久久久久久精品电影小说 | 国产有黄有色有爽视频| 噜噜噜噜噜久久久久久91| 国产亚洲一区二区精品| 久久女婷五月综合色啪小说| 一边亲一边摸免费视频| 美女高潮的动态| 欧美激情极品国产一区二区三区 | 亚洲丝袜综合中文字幕| 久久国产乱子免费精品| 亚洲欧美清纯卡通| 欧美老熟妇乱子伦牲交| 日本色播在线视频| 久久久色成人| 99re6热这里在线精品视频| 草草在线视频免费看| 美女cb高潮喷水在线观看| 国产在线视频一区二区| 26uuu在线亚洲综合色| 大片免费播放器 马上看| 最近最新中文字幕大全电影3| 国产成人精品久久久久久| 丰满人妻一区二区三区视频av| av女优亚洲男人天堂| 久久国产精品男人的天堂亚洲 | 色网站视频免费| 纵有疾风起免费观看全集完整版| 国产成人91sexporn| 久久国内精品自在自线图片| 亚洲精品一二三| av在线观看视频网站免费| 久久精品久久精品一区二区三区| 国产在线一区二区三区精| 成年美女黄网站色视频大全免费 | 七月丁香在线播放| 国产美女午夜福利| 成人亚洲精品一区在线观看 | 九九爱精品视频在线观看| 国产有黄有色有爽视频| 久久综合国产亚洲精品| 免费黄频网站在线观看国产| 亚洲真实伦在线观看| 免费观看无遮挡的男女| av视频免费观看在线观看| 精品久久久久久久久亚洲| 国产免费一区二区三区四区乱码| 国产精品伦人一区二区| 欧美成人午夜免费资源| 青青草视频在线视频观看| 性色avwww在线观看| 在线观看一区二区三区激情| 国产黄频视频在线观看| 国产在视频线精品| 亚洲欧美成人精品一区二区| 久久精品久久久久久噜噜老黄| 高清欧美精品videossex| 午夜免费男女啪啪视频观看| 久久99热这里只有精品18| 水蜜桃什么品种好| 国产熟女欧美一区二区| 天堂8中文在线网| 亚洲av在线观看美女高潮| 我的老师免费观看完整版| 在线观看美女被高潮喷水网站| 免费黄频网站在线观看国产| 男女下面进入的视频免费午夜| 精品一区二区三区视频在线| av福利片在线观看| 国产av国产精品国产| 男女无遮挡免费网站观看| 精品国产乱码久久久久久小说| 在线 av 中文字幕| 人体艺术视频欧美日本| 久久6这里有精品| 一级毛片aaaaaa免费看小| 26uuu在线亚洲综合色| 中文乱码字字幕精品一区二区三区| 伊人久久精品亚洲午夜| 狂野欧美激情性xxxx在线观看| 久久精品国产鲁丝片午夜精品| 男人舔奶头视频| 性色avwww在线观看| 伦精品一区二区三区| 五月玫瑰六月丁香| 中文字幕人妻熟人妻熟丝袜美| 一区二区三区精品91| 我要看黄色一级片免费的| 国产探花极品一区二区| 亚洲精品国产成人久久av| 国产乱人偷精品视频| 久久99精品国语久久久| 黄色视频在线播放观看不卡| 一级毛片黄色毛片免费观看视频| 天天躁日日操中文字幕| 亚洲欧美日韩东京热| 多毛熟女@视频| 涩涩av久久男人的天堂| 视频区图区小说| 少妇熟女欧美另类| 国产高潮美女av| 好男人视频免费观看在线| 国产精品人妻久久久久久| 日韩大片免费观看网站| 国产中年淑女户外野战色| 国产在线男女| 成年美女黄网站色视频大全免费 | 简卡轻食公司| 国产精品99久久久久久久久| 1000部很黄的大片| 天美传媒精品一区二区| 久久精品国产a三级三级三级| 国产精品偷伦视频观看了| 日韩成人av中文字幕在线观看| 欧美3d第一页| 久久久精品免费免费高清| 男女啪啪激烈高潮av片| 久久久久久久精品精品| 最近2019中文字幕mv第一页| 欧美三级亚洲精品| 深爱激情五月婷婷| 欧美日本视频| 日本wwww免费看| 中文字幕精品免费在线观看视频 | 国产久久久一区二区三区| 亚洲精品久久久久久婷婷小说| 偷拍熟女少妇极品色| 熟妇人妻不卡中文字幕| 美女主播在线视频| 插阴视频在线观看视频| 日韩欧美一区视频在线观看 | 在线观看免费日韩欧美大片 | 国产亚洲5aaaaa淫片| 亚洲色图综合在线观看| 欧美成人午夜免费资源| 亚洲精品日韩av片在线观看| 丰满少妇做爰视频| 久热这里只有精品99| 爱豆传媒免费全集在线观看| 国产精品一区www在线观看| 尾随美女入室| 激情 狠狠 欧美| 久久久久久久大尺度免费视频| 国产黄片美女视频| 亚洲精品国产成人久久av| tube8黄色片| 日韩人妻高清精品专区| 综合色丁香网| 精品一区二区三卡| 亚洲综合色惰| 免费黄色在线免费观看| 大陆偷拍与自拍| 日日摸夜夜添夜夜爱| 尤物成人国产欧美一区二区三区| 成人毛片a级毛片在线播放| 91久久精品国产一区二区三区| 亚洲不卡免费看| 91精品国产国语对白视频| 日日啪夜夜爽| 国产爱豆传媒在线观看| 久久精品久久精品一区二区三区| 亚洲av综合色区一区| 欧美精品一区二区大全| 日韩成人av中文字幕在线观看| 涩涩av久久男人的天堂| 婷婷色麻豆天堂久久| 丝袜脚勾引网站| 日韩,欧美,国产一区二区三区| 最近最新中文字幕免费大全7| 亚洲精品国产av蜜桃| 亚洲电影在线观看av| a级毛片免费高清观看在线播放| 男人狂女人下面高潮的视频| 美女脱内裤让男人舔精品视频| 在线观看免费高清a一片| 日本欧美视频一区| 街头女战士在线观看网站| 亚洲欧美一区二区三区国产| 老司机影院毛片| 色哟哟·www| 男人狂女人下面高潮的视频| 亚洲av中文av极速乱| 卡戴珊不雅视频在线播放| 成人美女网站在线观看视频| 国产av码专区亚洲av| 91精品国产国语对白视频| 夜夜爽夜夜爽视频| 中文欧美无线码| 日本爱情动作片www.在线观看| 国产精品人妻久久久久久| 日韩精品有码人妻一区| 下体分泌物呈黄色| 国产精品一区二区在线观看99| 99热国产这里只有精品6| 2018国产大陆天天弄谢| 久久韩国三级中文字幕| av黄色大香蕉| 日本与韩国留学比较| 好男人视频免费观看在线| 国产白丝娇喘喷水9色精品| 亚洲自偷自拍三级| 亚洲精品456在线播放app| 国产亚洲5aaaaa淫片| 国产免费一区二区三区四区乱码| av视频免费观看在线观看| 国产精品秋霞免费鲁丝片| a 毛片基地| 国产成人精品福利久久| 一边亲一边摸免费视频| av专区在线播放| 街头女战士在线观看网站| 大香蕉97超碰在线| 国产熟女欧美一区二区| 校园人妻丝袜中文字幕| 久久国产精品男人的天堂亚洲 | 国产精品一区二区在线不卡| 国产乱人偷精品视频| 国产黄色免费在线视频| 欧美性感艳星| 欧美激情国产日韩精品一区| 高清av免费在线| a级毛色黄片| 日日啪夜夜撸| 一本久久精品| 亚洲欧美日韩东京热| av国产精品久久久久影院| 日韩视频在线欧美| 久久精品久久久久久噜噜老黄| 日本欧美国产在线视频| 欧美日韩一区二区视频在线观看视频在线| 精品少妇久久久久久888优播| 一级爰片在线观看| 在线观看三级黄色| 久久精品国产鲁丝片午夜精品| 国产极品天堂在线| 欧美丝袜亚洲另类| 国产男女超爽视频在线观看| 一级毛片电影观看| 国产 一区 欧美 日韩| 国产成人免费观看mmmm| 色视频www国产| 永久网站在线| 亚洲av免费高清在线观看| 日本黄色日本黄色录像| 亚洲国产欧美人成| 男女无遮挡免费网站观看| 99热国产这里只有精品6| 韩国av在线不卡| 街头女战士在线观看网站| 男人和女人高潮做爰伦理| 国产成人一区二区在线| 欧美日韩视频高清一区二区三区二| 夜夜爽夜夜爽视频| 精品久久久久久电影网| 建设人人有责人人尽责人人享有的 | 国产av精品麻豆| 日韩强制内射视频| 美女中出高潮动态图| 成人特级av手机在线观看| 新久久久久国产一级毛片| 国产精品国产三级专区第一集| 国产免费视频播放在线视频| 国产男女超爽视频在线观看| 精品少妇久久久久久888优播| 成人美女网站在线观看视频| 成人黄色视频免费在线看| 精品一区二区三区视频在线| 99精国产麻豆久久婷婷| 亚洲国产色片| 久久久久久久久久人人人人人人| av国产精品久久久久影院| 久久女婷五月综合色啪小说| 亚洲色图综合在线观看| av天堂中文字幕网| 久久青草综合色| 80岁老熟妇乱子伦牲交| 深爱激情五月婷婷| 欧美高清成人免费视频www| 爱豆传媒免费全集在线观看| av专区在线播放| 亚洲一级一片aⅴ在线观看| 久热久热在线精品观看| 久久99热这里只有精品18| 干丝袜人妻中文字幕| 永久网站在线| 国产免费视频播放在线视频| 久久精品国产a三级三级三级| 国产色婷婷99| 久久人妻熟女aⅴ| 最新中文字幕久久久久| 免费观看性生交大片5| 国产精品蜜桃在线观看| 国产成人午夜福利电影在线观看| 亚洲精品自拍成人| a级毛片免费高清观看在线播放| 人妻 亚洲 视频| 又大又黄又爽视频免费| 国产无遮挡羞羞视频在线观看| 欧美日韩一区二区视频在线观看视频在线| 天堂中文最新版在线下载| 一级毛片久久久久久久久女| 亚洲av中文字字幕乱码综合| 免费观看性生交大片5| 久久久欧美国产精品| 在线观看三级黄色| 亚洲国产精品999| 免费久久久久久久精品成人欧美视频 | 王馨瑶露胸无遮挡在线观看| 少妇精品久久久久久久| 噜噜噜噜噜久久久久久91| 在线观看人妻少妇| 国产亚洲91精品色在线| 久久精品国产鲁丝片午夜精品| 观看av在线不卡| 精品亚洲成国产av| 欧美日韩精品成人综合77777| 在线观看免费高清a一片| 日韩国内少妇激情av| 男女边吃奶边做爰视频| 成人高潮视频无遮挡免费网站| 日韩三级伦理在线观看| 免费黄网站久久成人精品| 国产精品无大码| 久久久久精品性色| 一区在线观看完整版| 日韩一区二区三区影片| 欧美日韩一区二区视频在线观看视频在线| 老司机影院成人| 亚洲色图av天堂| 丰满迷人的少妇在线观看| 国产在线视频一区二区| 多毛熟女@视频| 国产日韩欧美在线精品| 国产精品女同一区二区软件| 又爽又黄a免费视频| 少妇被粗大猛烈的视频| 国产高清三级在线| 我的女老师完整版在线观看| 另类亚洲欧美激情| 日韩av免费高清视频| 精品亚洲成国产av| 日韩不卡一区二区三区视频在线| 亚洲av成人精品一区久久| 日本wwww免费看| 亚洲精品456在线播放app| 99久久中文字幕三级久久日本| 亚洲国产成人一精品久久久| 日韩三级伦理在线观看| 高清毛片免费看| 这个男人来自地球电影免费观看 | 女人十人毛片免费观看3o分钟| 一个人看视频在线观看www免费| 亚洲av福利一区| 日韩成人伦理影院| 一级毛片电影观看| 日本欧美视频一区| 日韩精品有码人妻一区| 国产在线一区二区三区精| 搡女人真爽免费视频火全软件| 美女中出高潮动态图| 最近最新中文字幕免费大全7| 18+在线观看网站| av国产免费在线观看| 插阴视频在线观看视频| 久久国产精品大桥未久av | 一级毛片电影观看| 亚洲av中文字字幕乱码综合| 91久久精品国产一区二区成人| 日本黄色日本黄色录像| 噜噜噜噜噜久久久久久91| 女性生殖器流出的白浆| av国产精品久久久久影院| 亚洲精华国产精华液的使用体验| 在线观看国产h片| 欧美高清成人免费视频www| 免费观看性生交大片5| 麻豆成人av视频| 搡老乐熟女国产| 亚洲av二区三区四区| 毛片一级片免费看久久久久| 国产淫语在线视频| 一二三四中文在线观看免费高清| 伊人久久精品亚洲午夜| 在线 av 中文字幕| 两个人的视频大全免费| av国产久精品久网站免费入址| 亚洲av中文av极速乱| 国产 精品1| 欧美bdsm另类| 晚上一个人看的免费电影| 日本与韩国留学比较| 国产色爽女视频免费观看| 18禁裸乳无遮挡动漫免费视频| 人人妻人人爽人人添夜夜欢视频 | 国产精品免费大片| 日本欧美视频一区| 国产av国产精品国产| 日韩国内少妇激情av| 在线 av 中文字幕| 国产精品久久久久久久电影| av国产久精品久网站免费入址| 人妻夜夜爽99麻豆av| 卡戴珊不雅视频在线播放| 最近中文字幕2019免费版| 国产免费一区二区三区四区乱码| 免费看光身美女| 一级a做视频免费观看| 亚洲av成人精品一区久久| 五月玫瑰六月丁香| 国产在线一区二区三区精| 久久久久人妻精品一区果冻| 尾随美女入室| 亚洲av免费高清在线观看| 1000部很黄的大片| 国产 精品1| 成人黄色视频免费在线看| 亚洲精品中文字幕在线视频 | 网址你懂的国产日韩在线| 在线免费十八禁| 亚洲激情五月婷婷啪啪| 国产乱来视频区| 成人毛片60女人毛片免费| 国产精品99久久99久久久不卡 | 99久国产av精品国产电影| 亚洲成人av在线免费| av在线播放精品| 国产永久视频网站| 麻豆成人午夜福利视频| 亚洲美女视频黄频| 在线观看人妻少妇| 国产精品人妻久久久影院| 如何舔出高潮| 一区二区三区精品91| 一级黄片播放器| 97超视频在线观看视频| 久久精品熟女亚洲av麻豆精品| 国产精品久久久久久av不卡| 99视频精品全部免费 在线| 韩国高清视频一区二区三区| 精华霜和精华液先用哪个| 国产精品久久久久久久久免| 国产亚洲午夜精品一区二区久久| 国产伦在线观看视频一区| 免费观看的影片在线观看| 高清黄色对白视频在线免费看 | 国产精品伦人一区二区| 日本猛色少妇xxxxx猛交久久| 国产成人a区在线观看| 美女国产视频在线观看| 一级毛片aaaaaa免费看小| 多毛熟女@视频| 99精国产麻豆久久婷婷| 久久久色成人| 在线看a的网站| 直男gayav资源| 菩萨蛮人人尽说江南好唐韦庄| 麻豆成人av视频| 日日摸夜夜添夜夜爱| 免费高清在线观看视频在线观看| 国产精品伦人一区二区| 国国产精品蜜臀av免费| 免费看光身美女| 少妇人妻精品综合一区二区| 五月伊人婷婷丁香| 国产又色又爽无遮挡免|